< Back to previous page
Project
SRP (Zwaartepunt): Targeting residual cancer cells: myeloma and melanoma as model diseases (SRP14)
Anti-tumor vaccination requires the identification of target antigens on resistant tumor subpopulations, adequate immune competence of the patients and the availability of efficient vaccination techniques.
Date:1 Nov 2012 → 31 Oct 2017
Keywords:Dendritic Cells, Tonic Pain, Evoked Potentials, Bispecific Antibodies, Immunotherapy, Immunology, Oncology
Disciplines:Immunology, Oncology, Hematology, Physiology, Laboratory medicine